PRELUDE CAPITAL MANAGEMENT, LLC - SPECTRUM PHARMACEUTICALS INC ownership

Quarter-by-quarter ownership
PRELUDE CAPITAL MANAGEMENT, LLC ownership history of SPECTRUM PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2023$45,013
-13.4%
46,889
+269.8%
0.00%0.0%
Q3 2020$52,000
+20.9%
12,6780.0%0.00%
+50.0%
Q2 2020$43,000
+43.3%
12,6780.0%0.00%0.0%
Q1 2020$30,000
-6.2%
12,678
+43.6%
0.00%
+100.0%
Q4 2019$32,000
+300.0%
8,831
+1098.2%
0.00%
Q1 2019$8,000
+33.3%
737
+3.1%
0.00%
Q4 2018$6,000
-98.5%
715
-97.0%
0.00%
-100.0%
Q3 2018$404,000
+1823.8%
24,050
+2305.0%
0.02%
+2200.0%
Q2 2018$21,000
-90.6%
1,000
-97.1%
0.00%
-95.2%
Q1 2017$223,000
+32.0%
34,301
-10.0%
0.02%
+5.0%
Q4 2016$169,000
+19.9%
38,110
+26.3%
0.02%
+33.3%
Q3 2016$141,000
+302.9%
30,183
+461.6%
0.02%
+200.0%
Q2 2016$35,000
+400.0%
5,374
+388.5%
0.01%
+400.0%
Q1 2015$7,000
-86.0%
1,100
-84.7%
0.00%
-85.7%
Q4 2014$50,000
-67.9%
7,200
-62.5%
0.01%
-68.2%
Q3 2014$156,000
+183.6%
19,200
+182.4%
0.02%
+214.3%
Q2 2014$55,000
-16.7%
6,800
-19.0%
0.01%
-22.2%
Q1 2014$66,000
+65.0%
8,400
+86.7%
0.01%
+28.6%
Q4 2013$40,000
+5.3%
4,5000.0%0.01%
+16.7%
Q3 2013$38,0004,5000.01%
Other shareholders
SPECTRUM PHARMACEUTICALS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Consonance Capital Management LP 6,963,756$145,960,0009.42%
Avoro Capital Advisors LLC 3,419,818$71,679,0002.76%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 300,000$6,285,0002.41%
Cormorant Asset Management, LP 1,200,000$25,152,0001.86%
Sio Capital Management, LLC 143,550$3,009,0001.66%
ASHFORD CAPITAL MANAGEMENT INC 425,702$8,923,0001.18%
PURA VIDA INVESTMENTS, LLC 130,700$2,739,0001.10%
Sonora Investment Management, LLC 298,967$6,266,0000.97%
PURA VIDA INVESTMENTS, LLC 100,000$2,096,0000.84%
J. Goldman & Co LP 694,338$14,553,0000.75%
View complete list of SPECTRUM PHARMACEUTICALS INC shareholders